Motilal Oswal initiates coverage on Zydus Wellness with a BUY rating and a target price of INR 575. The brokerage highlights the company's diversified health and nutrition portfolio, including sugar substitutes, glucose powders, skincare, and functional foods, with leadership positions in core categories. Recent acquisitions are noted for expanding its presence in high-protein snacks and digital nutrition, aligning with global consumption trends. Motilal Oswal believes Zydus can expand its user base, particularly among youth and affluent consumers.